eli lilly glp-1 news FDA just approved orforglipron (Foundayo), Lilly's oral receptor agonist for obesity Eli Lilly’s oral GLP-1 drug
Pay in 4 interest-free payments of $6.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26

























